Table 3.
Complications of ECP and TCP as seen in all eyes, neovascular eyes, and eyes with BCVA 20/400 or better.
| Total Cohort | NVG Cohort | BCVA >20/400 Cohort | |||||||
|---|---|---|---|---|---|---|---|---|---|
| ECP | TCP | p-Value * | ECP | TCP | p-Value * | ECP | TCP | p-Value * | |
| Sample Size | 42 | 44 | 7 | 18 | 18 | 7 | |||
| Acute Adverse Event (<1month), No. | |||||||||
| Fibrinoid reaction | 1 | 0 | 0.49 | 0 | 0 | n/a | 1 | 0 | 1.0 |
| Corneal decompensation | 1 | 0 | 0.5 | 0 | 0 | n/a | 0 | 0 | n/a |
| Post operative cylinder | 1 | 0 | 0.49 | 0 | 0 | n/a | 1 | 0 | 1.0 |
| Persistent AC reaction | 2 | 0 | 0.24 | 0 | 0 | n/a | 0 | 0 | n/a |
| Epitheliopathy | 1 | 0 | 0.49 | 1 | 0 | 1.0 | 0 | 0 | n/a |
| Choroidal hemorrhage | 1 | 1 | 1.0 | 0 | 0 | n/a | 1 | 0 | 1.0 |
| Vitritis | 1 | 0 | 0.49 | 0 | 0 | n/a | 0 | 0 | n/a |
| Macular Edema | 2 | 0 | 0.24 | 0 | 0 | n/a | 2 | 1 | 1.0 |
| Retinal Detachment | 1 | 1 | 1.0 | 0 | 0 | n/a | 0 | 0 | n/a |
| Hyphema | 0 | 1 | 1.0 | 0 | 1 | 1.0 | 0 | 0 | n/a |
| Persistent Lid Edema | 0 | 1 | 1.0 | 0 | 1 | 1.0 | 0 | 0 | n/a |
| Malignant glaucoma | 0 | 1 | 1.0 | 0 | 1 | 1.0 | 0 | 0 | n/a |
| Late Adverse Event (>1 month), No. | |||||||||
| Corneal decompensation | 4 | 1 | 0.20 | 0 | 1 | 1.0 | 2 | 0 | 1.0 |
| Phthisis | 0 | 9 | 0.003 | 0 | 7 | 0.13 | 0 | 0 | n/a |
| Hypotony | 2 | 4 | 1.0 | 0 | 2 | 1.0 | 2 | 0 | 1.0 |
| Uveitis | 1 | 1 | 1.0 | 0 | 0 | 1.0 | 1 | 1 | 0.49 |
| Progression to NLP | 2 | 6 | 0.017 | 1 | 4 | 0.30 | 1 | 0 | 1.0 |
* All p-values were from Fisher exact test. ECP: endoscopic cyclophotocoagulation; TCP: transcleral cyclophotocoagulation; AC: anterior chamber; RD: retinal detachment. NVG: neovascular glaucoma; CME: cystoid macular edema; NLP: no light perception.